Mapp Biopharmaceutical (United States)

Institution (Company)

Homepage Wikipedia ROR

Also Known As

Mapp Biopharmaceutical (United States)

160

Publications

28.6K

Citations

Authors

112

Concepts

About

Mapp Biopharmaceutical (United States) is a company institution in San Diego, United States known for medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	80	12.6K
2	Natural Sciences	5	9	183
3	Engineering	4	8	197
4	Health Sciences	2	8	156
5	Social Sciences	1	1	90

Mapp Biopharmaceutical (United States)

160

Publications

28.6K

Citations

Page 1

	Year	Citations
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp Xiangguo Qiu, Gary Wong, Jonathan Audet, Nature Emerging Infectious DiseasesViral PathogenesisEmergent VirusPathologyVirology	2014	976
Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques Gene G. Olinger, James Pettitt, Do Hyoung Kim, Proceedings of the National Academy of Sciences	2012	369
Cutting Edge: The Mucosal Adjuvant Cholera Toxin Redirects Vaccine Proteins into Olfactory Tissues Frederik W. van Ginkel, Raymond J. Jackson, Yoshikazu Yuki, The Journal of Immunology	2000	362
Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant Larry Zeitlin, James Pettitt, Corinne Scully, Proceedings of the National Academy of Sciences ImmunodeficienciesImmunologyImmunodominanceSimilar PotencyImmunotherapeutics	2011	228
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection Erica Ollmann Saphire, Sharon L. Schendel, Marnie L. Fusco, Cell VaccinationVirus EpidemiologyVaccine TargetSystematic AnalysisImmunology	2018	224
Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail James Pettitt, Larry Zeitlin, Do H. Kim, Science Translational Medicine	2013	220
Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases Scott J. Hecker, K. Raja Reddy, Olga Lomovskaya, Journal of Medicinal Chemistry	2020	200
Structures of protective antibodies reveal sites of vulnerability on Ebola virus Charles D. Murin, Marnie L. Fusco, Zachary A. Bornholdt, Proceedings of the National Academy of Sciences	2014	192
Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses Anna Z. Wec, Andrew S. Herbert, Charles D. Murin, Cell VaccinationVirus EpidemiologyViral DiagnosticsVaccine TargetBroad Protection	2017	173
A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens Kade D. Roberts, Yan Zhu, Mohammad Abul Kalam Azad, Nature Communications	2022	141

Page 1